Q1 Earnings Estimate for MREO Issued By Leerink Partnrs
Mereo BioPharma Group plc (NASDAQ:MREO – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Mereo BioPharma Group in a report issued on Wednesday, March 26th. Leerink Partnrs analyst J. Schwartz forecasts that the company will post earnings per share of $0.07 for […]
